🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK945237 belongs to the Bacterial Type II Topoisomerase Inhibitor (BTI) cl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01039610
Treatments Being Tested
This is a clinical study organized to collect clinical data to better defin...
Status
Terminated
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00493038
Treatments Being Tested
To demonstrate that multiple-dose administration of oral therapeutic and su...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2020-01-14
Trial ID
NCT04281342
This study will investigate the effects of therapeutic and supratherapeutic...
Status
Completed
Location
Clinical Pharmacology of Miami (CPMI), LLC
Start Date
2021-06-01
Trial ID
NCT04818229
Treatments Being Tested
This is a double-blind (vis-a-vis lenvatinib), randomized, placebo-controll...
Status
Completed
Location
Charles River
Start Date
2010-12
Trial ID
NCT01525394
Treatments Being Tested
The objective of this study was to evaluate the effects of cebranopadol (GR...
Status
Completed
Location
US001 Contract research organization
Start Date
2013-07-10
Trial ID
NCT03958123
The purpose of this study is to assess the effects on placebo-corrected cha...
Status
Completed
Location
Celerion
Start Date
2018-07-13
Trial ID
NCT03606057
Treatments Being Tested
The main purpose of this study is to examine the effect of dapagliflozin on...
Status
Completed
Location
Research Site
Start Date
2007-07
Trial ID
NCT00688493
Treatments Being Tested
The purpose of this study is to evaluate the effect of JNJ-63623872 on the ...
Status
Completed
Location
Multiple Locations
Start Date
2016-01
Trial ID
NCT02658825
The purpose of the study is to evaluate the effects of clinical and high cl...
Status
Completed
Location
ICON Lenexa
Start Date
2023-04-12
Trial ID
NCT05818852
Treatments Being Tested